[26-year-old patient with cutaneous leishmaniasis and an initial diabetes mellitus manifestation].
Herrmann
B L
BL
Abteilung für Endokrinologie, Universitätsklinikum Essen, Gesamthochschule Essen.
Saller
B
B
Sauer
J
J
Brockmeyer
N
N
Mann
K
K
D000328:Adult; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003922:Diabetes Mellitus, Type 1 / Q000139:chemically induced* / Q000175:diagnosis; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000175:diagnosis / Q000188:drug therapy*; D008047:Lip Diseases / Q000175:diagnosis / Q000188:drug therapy*; D009668:Nose Diseases / Q000175:diagnosis / Q000188:drug therapy*; D010419:Pentamidine / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence
D000981:Antiprotozoal Agents; D010419:Pentamidine
26jährige Patientin mit kutaner Leishmaniose und Erstmanifestation eines Diabetes mellitus.